CCG 203769
CCG 203769 is a thiadiazolidinone-derived compound that selectively inhibits the RGS4-Gαo protein-protein interaction with an IC50 of 17 nM. This tool compound facilitates the study of RGS4 function in cellular signaling pathways and is used in both in vitro biochemical assays and cellular research models.
Product Specifications
CAS Number
410074-60-1
Product Name Alternative
Dopamine Receptor, DopamineReceptor, D2 receptor, CCG 203769, CCG203769, CCG-203769, 4-butyl-2-ethyl-1,2,4-thiadiazolidine-3,5-dione, GSK3, GSK3β, GSK-3β, RGS16, RGS19, RGS4, RGS4 inhibitor 11b, RGS8, Thiadiazolidinone (TDZD) deriv. 6
Field of Research
Neuroscience, Pharmacology & Drug Discovery, Signal Transduction, Stem Cell & Developmental Biology
Purity
99.46% (May vary between batches)
Solubility
DMSO:50 mg/mL (247.19 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (9.89 mM)
Smiles
CCCCn1c (=O) sn (CC) c1=O
Molecular Formula
C8H14N2O2S
Molecular Weight
202.27
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog